6.95
price down icon0.43%   -0.03
after-market Handel nachbörslich: 6.98 0.03 +0.43%
loading
Schlusskurs vom Vortag:
$6.98
Offen:
$6.96
24-Stunden-Volumen:
266.59K
Relative Volume:
1.37
Marktkapitalisierung:
$148.38M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-7.3936
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
+5.30%
1M Leistung:
+1.02%
6M Leistung:
+75.06%
1J Leistung:
+261.98%
1-Tages-Spanne:
Value
$6.51
$7.14
1-Wochen-Bereich:
Value
$6.4675
$7.20
52-Wochen-Spanne:
Value
$1.71
$7.20

Exagen Inc Stock (XGN) Company Profile

Name
Firmenname
Exagen Inc
Name
Telefon
(760) 560-1501
Name
Adresse
1261 LIBERTY WAY, VISTA, CA
Name
Mitarbeiter
209
Name
Twitter
@ExagenInc
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
XGN's Discussions on Twitter

Vergleichen Sie XGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
XGN
Exagen Inc
6.95 144.24M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
402.82 148.60B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.90 132.07B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
513.36 40.34B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.92 30.82B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
140.33 23.70B 15.50B 1.33B 2.16B 7.34

Exagen Inc Stock (XGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-08-05 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Fortgesetzt Cowen Outperform
2021-04-15 Eingeleitet Canaccord Genuity Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2020-10-08 Eingeleitet BTIG Research Buy
2020-06-02 Fortgesetzt Cantor Fitzgerald Overweight
2019-10-14 Eingeleitet Cantor Fitzgerald Overweight
2019-10-14 Eingeleitet Cowen Outperform
2019-10-14 Eingeleitet William Blair Outperform
Alle ansehen

Exagen Inc Aktie (XGN) Neueste Nachrichten

pulisher
May 31, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

May 31, 2025
pulisher
May 29, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria

May 29, 2025
pulisher
May 19, 2025

Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st

May 18, 2025
pulisher
May 17, 2025

Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World

May 17, 2025
pulisher
May 16, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World

May 15, 2025
pulisher
May 13, 2025

Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen prices public offering of common stock - MSN

May 13, 2025
pulisher
May 11, 2025

Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 10, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire

May 10, 2025
pulisher
May 10, 2025

Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN

May 10, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan

May 09, 2025
pulisher
May 09, 2025

Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st

May 09, 2025
pulisher
May 09, 2025

Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

May 09, 2025
pulisher
May 09, 2025

Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks

May 09, 2025
pulisher
May 08, 2025

Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph

May 08, 2025
pulisher
May 08, 2025

William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 08, 2025
pulisher
May 07, 2025

Exagen announces common stock offering, no amount given - TipRanks

May 07, 2025
pulisher
May 07, 2025

Exagen (XGN) Announces Public Offering of Common Stock | XGN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Exagen Inc. Announces Proposed Public Offering of Common Stock - The Manila Times

May 07, 2025
pulisher
May 07, 2025

Exagen price target raised to $9 from $5 at BTIG - TipRanks

May 07, 2025
pulisher
May 07, 2025

Exagen (XGN) Sees Price Target Increase Following Strong Q1 Performance | XGN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Marshall Wace LLP Acquires Shares of 16,048 Exagen Inc. (NASDAQ:XGN) - Defense World

May 07, 2025

Finanzdaten der Exagen Inc-Aktie (XGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$173.34
price up icon 0.78%
diagnostics_research WAT
$349.24
price down icon 1.71%
diagnostics_research LH
$248.97
price up icon 0.90%
$157.73
price down icon 0.20%
diagnostics_research MTD
$1,155.52
price down icon 1.51%
diagnostics_research IQV
$140.33
price down icon 0.49%
Kapitalisierung:     |  Volumen (24h):